A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis.

MLA

Long, Merete B., et al. “A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas Aeruginosa in Patients with Bronchiectasis.” American Journal of Respiratory & Critical Care Medicine, vol. 210, no. 1, July 2024, pp. 35–46. EBSCOhost, https://doi.org/10.1164/rccm.202308-1403OC.

APA

Long, M. B., Gilmour, A., Kehl, M., Tabor, D. E., Keller, A. E., Warrener, P., Gopalakrishnan, V., Rosengren, S., Crichton, M. L., McIntosh, E., Giam, Y. H., Keir, H. R., Brailsford, W., Hughes, R., Belvisi, M. G., Sellman, B. R., DiGiandomenico, A., & Chalmers, J. D. (2024). A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis. American Journal of Respiratory & Critical Care Medicine, 210(1), 35–46. https://doi.org/10.1164/rccm.202308-1403OC

Chicago

Long, Merete B., Amy Gilmour, Margaret Kehl, David E. Tabor, Ashley E. Keller, Paul Warrener, Vancheswaran Gopalakrishnan, et al. 2024. “A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas Aeruginosa in Patients with Bronchiectasis.” American Journal of Respiratory & Critical Care Medicine 210 (1): 35–46. doi:10.1164/rccm.202308-1403OC.